Clinical trials recruiting in Fujian, China
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 2Phase 2 3Phase 3 4Not applicable 3
Conditions recruiting in Fujian, China
Recruiting trials in Fujian, China
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
- A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- China Cognition and Aging Study
- Chinese Psoriasis Real World Evidence Research
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
- The Chinese Familial Alzheimer's Network
- Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Common questions
How many clinical trials are recruiting in Fujian, China?
10 recruiting trials have at least one study site in Fujian, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.